Documentation scientifique sur PCA3

Vous trouverez ci-dessous une liste des articles et présentations scientifiques sur le PCA3, mise à jour de façon régulière. Vous pouvez consulter les résumés de ces articles scientifiques ou les présentations en cliquant sur les liens fournis, lorsque disponibles.

Articles scientifiques

  1. Whitman, E.J. et al, PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume, The Journal of Urology, 2008 November, 180(5):1975-1979
  2. Ankerst, D.P. et al, Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3, The Journal of Urology, 2008 October; 180(4): 1303-1308
  3. Haese, A. et al, Clinical utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy, European Urology (2008), doi: 10.1016/j.eururo.2008.06.071.
  4. Nakanishi, H. et al, PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor
    Volume: Implication in Selecting Candidates for Active Surveillance    , The Journal of Urology, 2008 May;179(5):1804-9
  5. Deras, IL et al., PCA3: a molecular urine assay for predicting prostate biopsy outcome, The Journal of Urology, 2008 Apr;179(4):1587-92
  6. Shappell, S.B., Clinical Utility of Prostate Carcinoma MolecularDiagnostic Tests, Reviews in Urology, 2008;10(1):44-69
  7. Popa, Ion et al., Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization, Modern Pathology, 2007 Nov;20(11):1121-7
  8. Marks, L.S. et al., PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy, Urology, 69(3): 532-535, mars 2007
  9. Fradet, Y. et al, uPM3, A New Molecular Urine Test for the Detection of Prostate Cancer, Urology 64 (2): 311-316, août 2004
  10. Tinzl, M. et al, DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer, European Urology, Vol. 46(2), pages 182-187, août 2004
  11. Schalken, JA et al, New Targets for Therapy in Prostate Cancer: Differential Display Code 3 (DD3PCA3), a Highly Prostate Cancer-Specific Gene, Urology, 62 (5 Suppl 1):34-43, novembre 2003
  12. Hessels, D. et al., DD3PCA3-Based Molecular Urine Analysis for the Diagnosis of Prostate Cancer, European Urology, Vol. 44(1), pages 8-16, juillet 2003
  13. Leff, DN, Front-Running DD3PCA3 Gene Faced Off PSA Test of Prostate Carcinoma in First-Shot Urology Clinic Line-Up, BioWorld Today, juillet 10, 2003
  14. deKok, J. et al, DD3PCA3, a Very Sensitive and Specific Marker to Detect Prostate Tumors, Cancer Research, vol. 62, pages 2695-2698, mai 2002
  15. Bussemakers, M. et al, DD3: A New Prostate-Specific Gene, Highly Overexpressed in Prostate Cancer, Cancer Research, Vol. 59, pages 5975-5979, décembre 1999

Présentations

  1. Schalken, J., PCA3 Is a Novel Genetic Marker, EAU Congress News, p. 17, 23 mars 2007
  2. Groskopf, J. et al., The PCA3 Score is Independent of Prostate Gland Volume, and can Synergize with other Patient Information for Predicting Biopsy Outcome, EAU, mars 2007
  3. Haese, A. et al, The Value of the PCA3 Assay in Guiding Decision Which Men With a Negative Prostate Biopsy Need Immediate Repeat Biopsy: Preliminary European Data, EAU, mars 2007
  4. Nakanishi, H. et al, The Relationship Between PCA3 Score and Tumor Volume in Prostatectomy Samples, EAU, mars 2007
  5. Overmyer, M., New PCa Assay Aids Critical Diagnostic Decisions, Urology Times, juillet 2006
  6. Fradet, Y. et al, PCA3 Molecular Urine Test: Development of a Method to Aid in Prostate Cancer Diagnosis, AUA, mai 2006
  7. Marks, L.S. et al, Specificity of the PCA3 Molecular Urine Test for Prostate Cancer, AUA, mai 2006
  8. Fradet, Y. et al, Performance of the PCA3 Urine Test on Subjects with Previous Negative Prostate Biopsies, AUA, mai 2006
  9. Groskopf, J. et al, PCA3 Molecular Urine Assay: Characterization of a Method to Aid in the Diagnosis of Prostate Cancer, AUA, mai 2006
  10. Bostwick, DG, PCA3Plus™: The Next Generation Genetic Test for Prostate Cancer Risk, AUA, mai 2006
  11. Têtu, B. et al, PCA3DD3 Gene Expression is a Marker of Prostate Cancer, USCAP, février 2005